Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced ...

Piramal Pharma said that its subsidiary Piramal Critical Care (PCC) has launched Chlorpromazine Hydrochloride for Injection in various strengths in the US market.

Piramal Critical Care (PCC), a complex hospital generics business; and the India Consumer Healthcare business selling over-the-counter products. For more news like this visit The Economic Times.

The pharmaceutical company's consolidated net profit tumbled 63.6% to Rs 3.68 crore despite of 12.54% increase in revenue from operations to Rs 2,204.22 crore in Q3 FY25 over Q3 FY24.

as President Trump indicated higher tariffs on imported products including pharmaceuticals, as a step to bolster their local production. On the overall biotech landscape, Piramal said ...

Piramal Critical Care (PCC), a complex hospital generics business; and the India Consumer Healthcare business selling over-the-counter products.

Power Brands contributed to 48% of total ICH sales - Excluding i-range, which was impacted by regulatory price control, growth in power brands was about 26% for 9MFY25 - Added 16 new products and ...

Piramal Critical Care (PCC), a complex hospital generics business; and the India Consumer Healthcare business, selling over-the-counter consumer and wellness products. In addition, one of PPL's ...